Keratin 19 mRNA is detectable by RT-PCR in lymph nodes of patients without breast cancer
1997

Detection of Keratin 19 mRNA in Lymph Nodes of Patients Without Breast Cancer

Sample size: 40 publication Evidence: moderate

Author Information

Author(s): K Yun, J Gunn, AEH Merrie, LV Phillips, JL McCall

Primary Institution: University of Otago Medical School

Hypothesis

Can K19 mRNA be detected in lymph nodes of patients without breast cancer?

Conclusion

K19 mRNA is expressed in a significant number of lymph nodes from patients with benign bowel diseases, suggesting that its presence is not exclusive to cancer.

Supporting Evidence

  • 31 of 40 lymph nodes from patients with benign bowel diseases showed K19 mRNA.
  • None of the control lymph nodes without epithelial malignancy showed K19 expression.
  • RNA extractions included blank samples to rule out reagent contamination.

Takeaway

The study found that some patients without breast cancer have a certain marker in their lymph nodes, which might not mean they have cancer.

Methodology

RT-PCR was used to detect K19 mRNA in lymph nodes, with careful dissection to avoid contamination.

Potential Biases

Potential for contamination in sample collection and processing.

Limitations

The study's sample size is relatively small and focused on specific patient groups.

Participant Demographics

Patients included those with benign bowel diseases and breast cancer patients.

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication